$1.30
00.00%
Pre-Market: Sep 20, 4:00 PM EDT
15 minutes delayed
Nektar Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Nektar Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.25 | $-0.20 | -25.0 % |
Mar 2024 | 2024-05-09 | $-0.19 | $-0.19 | 0.00 % |
Dec 2023 | 2024-03-04 | $-0.22 | $-0.21 | -4.76 % |
Sep 2023 | 2023-11-07 | $-0.19 | $-0.20 | 5.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $23.49M | $17.54M | 33.9 % |
Mar 2024 | 2024-05-09 | $21.64M | $15.34M | 41.1 % |
Dec 2023 | 2024-03-04 | $23.89M | $18.05M | 32.3 % |
Sep 2023 | 2023-11-07 | $24.14M | $21.31M | 13.3 % |
Nektar Therapeutics (NKTR) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.25, which missed the estimate of $-0.20.
The Actual Revenue was $23.5M, which beat the estimate of $17.5M.
Browse earnings estimates, EPS, and revenue on all stocks.